SCHEMBL10128074

SCHEMBL10128074

CCc1ccc2oc3c(-c4ccc(-c5nnc6c7ccccc7ccn56)cc4)cc(CC)cc3c2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
RAB9A P51151 3/20 0.34
TP53 P04637 2/20 0.34
HCRTR1 O43613 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
SIRT2 Q8IXJ6 3/20 0.32
SIRT1 Q96EB6 3/20 0.32
ALDH1A1 P00352 6/20 0.32
KDM4E B2RXH2 5/20 0.32
HSD17B10 Q99714 2/20 0.32
HPGD P15428 2/20 0.32
GLA P06280 2/20 0.32
GAA P10253 2/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10148819 0.94 MAPT (0.34) MAPTSMN1; SMN2RAB9ATP53HCRTR1
SCHEMBL10128073 0.91 RAB9A (0.33) MAPTSMN1; SMN2RAB9ATP53HCRTR1
SCHEMBL10128078 0.89 HSD11B1 (0.38) SIRT2SIRT1
SCHEMBL10128081 0.88 IKBKE (0.31) MAPTSMN1; SMN2RAB9AALDH1A1KDM4E
SCHEMBL10128065 0.84 MAPT (0.38) MAPTSMN1; SMN2RAB9ATP53ALOX15
SCHEMBL10128115 0.83 MAPT (0.39) MAPTSMN1; SMN2TP53ALOX15SIRT2
SCHEMBL10128083 0.82 PIM1 (0.36) MAPTTP53ALOX15MAPK1SIRT2
SCHEMBL10128099 0.82 PIM1 (0.36) MAPTTP53ALOX15MAPK1SIRT2
SCHEMBL10128084 0.82 NPSR1 (0.31) MAPTSMN1; SMN2RAB9ATP53HCRTR1
SCHEMBL16715964 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 MAPT 1271/4885SMN1; SMN2 4667/4885RAB9A 3001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.